AF
| |
Atle Fund Management AB13F | |
| Atle Fund Management AB | |
| Last update 2025-07-14 | 37 Stocks (1 new) |
| Value $234.00 Mil | Turnover 10 % |
Atle Fund Management AB Top Holdings of 2025-06-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and Co | 38,721 | 30,184.2 | +11.90% | 12.920 | +1.37% | 0.000 | +6.18% | +3.93% | 717,596.0 | Drug Manufacturers | |
ABBV | AbbVie Inc | 86,933 | 16,136.5 | -2.57% | 6.910 | -0.21% | 0.000 | +7.92% | +9.80% | 338,301.5 | Drug Manufacturers | |
BSX | Boston Scientific Corp | 126,185 | 13,553.5 | -4.60% | 5.800 | -0.27% | 0.010 | +10.67% | +16.80% | 154,350.6 | Medical Devices & Instruments | |
NBIX | Neurocrine Biosciences Inc | 88,392 | 11,110.0 | +16.49% | 4.750 | +0.67% | 0.090 | +42.41% | -1.00% | 13,373.3 | Drug Manufacturers | |
MRK | Merck & Co Inc | 139,172 | 11,016.9 | +9.00% | 4.710 | +0.39% | 0.010 | +6.74% | -14.32% | 210,098.0 | Drug Manufacturers | |
SYK | Stryker Corp | 27,466 | 10,866.4 | +19.43% | 4.650 | +0.76% | 0.010 | +11.00% | +9.21% | 149,602.3 | Medical Devices & Instruments | |
VRTX | Vertex Pharmaceuticals Inc | 24,328 | 10,830.8 | +6.66% | 4.640 | +0.29% | 0.010 | -4.74% | +17.30% | 121,298.2 | Biotechnology | |
ISRG | Intuitive Surgical Inc | 18,559 | 10,085.1 | +20.94% | 4.320 | +0.75% | 0.010 | +5.37% | -1.06% | 185,101.5 | Medical Devices & Instruments | |
TMO | Thermo Fisher Scientific Inc | 24,266 | 9,838.9 | +6.16% | 4.210 | +0.24% | 0.010 | -5.24% | -18.09% | 160,563.3 | Medical Diagnostics & Research | |
COR | Cencora Inc | 31,466 | 9,435.1 | -0.28% | 4.040 | -0.01% | 0.020 | +4.69% | +32.77% | 57,577.2 | Medical Distribution |
Atle Fund Management AB's Historical Top Holdings Breakdowns
Atle Fund Management AB's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
UNH | UnitedHealth Group Inc | 2025-06-30 | Reduce Reduce | -2.79% | 274.35 ($384.44) 599.47 | $300.58 | -21.81% | Reduce -46.76% | 13,727 | -12,055 | |
LLY | Eli Lilly and Co | 2025-06-30 | Add Add | +1.37% | 713.71 ($777.85) 898.95 | $799.34 | 2.76% | Add 11.9% | 38,721 | 4,119 | |
SYK | Stryker Corp | 2025-06-30 | Add Add | +0.76% | 337.37 ($374.07) 395.63 | $391.46 | 4.65% | Add 19.43% | 27,466 | 4,468 | |
ISRG | Intuitive Surgical Inc | 2025-06-30 | Add Add | +0.75% | 451.58 ($522.44) 565.94 | $516.44 | -1.15% | Add 20.94% | 18,559 | 3,214 | |
NBIX | Neurocrine Biosciences Inc | 2025-06-30 | Add Add | +0.67% | 87.54 ($114.62) 128.18 | $135.13 | 17.89% | Add 16.49% | 88,392 | 12,511 | |
MIRM | Mirum Pharmaceuticals Inc | 2025-06-30 | Add Add | +0.65% | 38.39 ($44.53) 51.11 | $53.28 | 19.65% | Add 38.37% | 106,912 | 29,649 | |
AUTL | Autolus Therapeutics PLC | 2025-06-30 | Add Add | +0.61% | 1.14 ($1.65) 2.35 | $2.65 | 60.61% | Add 130.48% | 1,105,461 | 625,817 | |
IRON | Disc Medicine Inc | 2025-06-30 | New Buy New Buy | +0.56% | 34.28 ($47.01) 55 | $57.74 | 22.82% | New holding | 24,652 | 24,652 | |
MRUS | Merus NV | 2025-06-30 | Add Add | +0.55% | 34.89 ($46.93) 62.42 | $55.62 | 18.52% | Add 69.7% | 59,889 | 24,597 | |
ACLX | Arcellx Inc | 2025-06-30 | Reduce Reduce | -0.53% | 52.8 ($62.31) 68.1 | $69.92 | 12.21% | Reduce -41.74% | 25,732 | -18,439 |
Atle Fund Management AB Total Holding History ($B)
Atle Fund Management AB's Asset Allocation
Atle Fund Management AB Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Atle Fund Management AB's Hypothetical Growth since 2025-06-30
Atle Fund Management AB's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Atle Fund Management AB's Holdings Heat Map
Size field:
Atle Fund Management AB's Holdings Bubble Chart
Atle Fund Management AB News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers